Michael Andrew Chambers, Director at Sarepta Therapeutics, holds 292.31K shares in Sarepta Therapeutics (Ticker: SRPT). Most recently, Michael Andrew Chambers Bought $37,038 shares of Sarepta Therapeutics on Aug 20, 2024 for an estimated value of 4.96M.
What is the percentage of profitable transactions made by Michael Andrew Chambers?
The percentage of profitable transactions made by Michael Andrew Chambers is 83%.
What is the average return per transaction made by Michael Andrew Chambers?
The average return per transaction made by Michael Andrew Chambers is 8.50%.
What stocks does Michael Andrew Chambers hold?
Michael Andrew Chambers holds: SRPT stocks.
What was Michael Andrew Chambers’s latest transaction?
Michael Andrew Chambers latest transaction was an Informative Buy of $4.96M.
What was Michael Andrew Chambers's most profitable transaction?
Michael Andrew Chambers’s most profitable transaction was an Informative Buy of SRPT stock on August 14, 2023. The return on the trade was 18.30%.
What is Michael Andrew Chambers's role in Sarepta Therapeutics?
Michael Andrew Chambers's role in Sarepta Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.